STRW

• On August 6, 2026, the Board of Directors declared a cash dividend of $0.17 per common share.
• The company is a self-administered REIT owning 142 healthcare facilities with 15,500 beds across ten states.
• The dividend was announced via a press release filed as Exhibit 99.1 to the 8-K.
• The event was reported under Item 8.01 (Other Events) as a routine dividend declaration.

8.01 Other Events · 9.01 Financial Statements and Exhibits

• On August 6, 2026, Strawberry Fields REIT issued a press release and investor presentation for Q2 2026 results.
• The company closed a Corporate Credit Facility on June 18, 2026, with up to $300 million availability, comprising a $100 million term loan and $200 million revolving line of credit, at SOFR +2.75%.
• On April 21, 2026, the company contracted to acquire a hospital campus near Kansas City, Missouri for $10.4 million, expected to close in Q3 2026.
• The company collected 100% of contractual rents in Q2 2026.

7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits

• On June 18, 2026, Strawberry Fields REIT, Inc. closed its Corporate Credit Facility with up to $300 million in availability.
• Both the Term Loan and Revolving Loan bear interest at the greater of 1-month CME Term SOFR plus 275 basis points or 5.50% per annum.
• Both loans mature on June 18, 2029, with two one-year extension options, and are secured by a portion of SFRLP's assets and guaranteed by the Company and certain real estate subsidiaries.
• Proceeds will be used to refinance existing secured bank debt, support acquisition growth, working capital, and general corporate purposes.

1.01 Entry into a Material Definitive Agreement · 9.01 Financial Statements and Exhibits

• Each unit consisted of NIS 1,000 par value Bonds (Series C) and 16 Warrants (Series 1); the bonds carry a fixed annual interest rate of 6.85%.
• The warrants are exercisable into one share of common stock each at an exercise price of NIS 39.8 (approximately $13.69 as of May 19, 2026), expiring June 30, 2027.
• The offering was made solely to Israeli residents and not to U.S. persons, relying on Regulation S exemptions; the securities will not be listed on any U.S. exchange.
• The 2,603,936 shares underlying the warrants will be registered under an effective Form S-3 registration statement, with a prospectus supplement filed on May 20, 2026.

3.02 Unregistered Sales of Equity Securities · 9.01 Financial Statements and Exhibits

• On May 7, 2026, the Board of Directors declared a cash dividend of $0.17 per common share.
• The company announced the dividend in a press release dated May 8, 2026.
• Strawberry Fields REIT is a self-administered REIT owning 143 healthcare facilities with over 15,600 beds.
• The dividend was reported under Item 8.01 as an other event and included as Exhibit 99.1.

8.01 Other Events · 9.01 Financial Statements and Exhibits

• Net income for Q1 2026 was $9.5 million, up from $7.0 million in Q1 2025; rental income received was $40.0 million vs. $37.3 million.
• The company signed a term sheet for a Corporate Credit Facility with up to $300 million availability, comprising a $100 million term loan and $200 million revolving line of credit, at SOFR +2.75%, expected to close in Q2 2026.
• On April 21, 2026, the company contracted to acquire a hospital campus near Kansas City, Missouri for $8.6 million, including a 60-bed hospital and 99-bed skilled nursing facility, to be added to an existing master lease with initial base rents of $860,000 and 3% annual increases.
• The company collected 100% of contractual rents in Q1 2026 and reported results via press release and investor presentation furnished under Item 7.01.

7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits

• All six director nominees were elected: Moishe Gubin, Michael Blisko, Jack Levine, Mark Myers, Stanford Gertz, and Ted Lerman.
• Shareholders ratified Hacker, Johnson & Smith, P.A. as independent auditor for fiscal year 2026 (10,433,324 for, 359,142 against).
• A proposal to approve adjournment of the meeting, if necessary, was approved (8,843,842 for, 1,877,111 against).
• The report was filed under Item 5.07 to disclose the voting results of the annual meeting.

5.07 Submission of Matters to a Vote of Security Holders · 9.01 Financial Statements and Exhibits

• The amendment adds Cantor Fitzgerald & Co. as an agent and removes Wedbush Securities Inc. from the sales agreement.
• The company filed a prospectus supplement on April 14, 2026, in connection with the offering of shares under the agreement.
• The offering is made under the company's existing Form S-3 registration statement filed on July 25, 2024.
• The company also filed updated risk factors as an exhibit to the 8-K.

1.01 Entry into a Material Definitive Agreement · 8.01 Other Events · 9.01 Financial Statements and Exhibits